พบ "Public health policy"ทั้งหมด 1,226 ผลลัพธ์
เรียงลำดับตาม
ฮ - ก

Cost-utility analysis of 10- and 13-valent pneumococcal conjugate vaccines: Protection at what price in the Thai context? (2013)

Cost-utility analysis of 10- and 13-valent pneumococcal conjugate vaccines: Protection at what price in the Thai context? Wantanee Kulpenga, b, , , , Pattara Leelahavaronga, , Waranya Rattanavipaponga, , Vorasith Sornsrivichaib, , Henry C. Baggettc, , Aronrag Meeyaia, d, , , Warunee Punpaniche, ,

Cost-effectiveness of alginic acid in combination with proton pump inhibitor for the treatment of gastroesophageal reflux disease in systemic sclerosis patients

Systemic sclerosis (SSc) patients often become refractory to proton pump inhibitors (PPI)—a standard treatment for gastroesophageal reflux disease (GERD)—and intolerant to PPI in combination with domperidone. PPI with alginic acid is an alternative treatment option, but alginic acid is costly. We

Cost-effectiveness and budget impact analysis of facility-based screening and treatment of hepatitis C in Punjab state of India

ABSTRACT Objective Despite treatment availability, chronic hepatitis C virus (HCV) public health burden is rising in India due to lack of timely diagnosis. Therefore, we aim to assess incremental cost per quality-adjusted life year (QALY) for one-time universal screening followed by treatment of

Cost-effectiveness analysis of typhoid vaccination in Lao PDR

Abstract Background Typhoid vaccination has been shown to be an effective intervention to prevent enteric fever and is under consideration for inclusion in the national immunization program in Lao PDR. Methods A cost-utility analysis was performed using an age-structured static decision tree

Cost-Effectiveness Analysis of Thiazolidinediones in Uncontrolled Type 2 Diabetic Patients Receiving Sulfonylureas and Metformin in Thailand (2008)

Cost-Effectiveness Analysis of Thiazolidinediones in Uncontrolled Type 2 Diabetic Patients Receiving Sulfonylureas and Metformin in Thailand. Suphachai Chirakup1,2 Nathorn Chaiyakunapruk1,3,4 Usa Chaikledkeaw5,6 Petcharat Pongcharoensuk5 Boonsong Ongphiphadhanakul7 Stephane Roze8 William J. Val

Cost utility and budget impact analysis of drug treatments in pulmonary arterial hypertension associated with congenital heart diseases in Thailand

Objective: This study aims to compare the lifetime costs and health outcomes of both first-line and sequential combination treatments with standard treatment for pulmonary arterial hypertension (PAH) associated with congenital heart disease (CHD) (PAH-CHD) patients. Methods: A cost-utility analysis

Cost for RRTTPR activities by community-based organisations (CBOs) in Thailand

This study was written in March, 2020. It employed a retrospective, cross-sectional observational design to estimate the empirical and unit costs of service provision across the RRTTPR cascade. The analysis utilised gross costing methods applying a top-down approach. The research team obtained cost

CORRECTION: Aspirin may help older colon cancer patients live longer

[Corrects headline to sentence case in story posted Dec 7, 2012 as 20121207elin003.]NEW YORK (Reuters Health) – Older adults with colon cancer who were prescribed a daily aspirin were less likely to die than those who weren’t, according to a new study.While the results need to be confirmed with more

Convergence of Digital Health Platforms and Health Information Systems (HIS) Implementation in Thailand (ConvergeDH) – Year 3

Digital health and Health Information Systems (HIS) are dramatically altering the landscape for health. Thailand achieved Universal Health Coverage (UHC) in 2002. However, the delivery of health services relies heavily on manpower without digitisation, and the COVID-19 pandemic has exposed the lack of adequate digital health platforms in the countr
10 / หน้า